Autologous Mesenchymal Stem Cells Show More Benefit on Systolic Function Compared to Bone Marrow Mononuclear Cells in a Porcine Model of Chronic Myocardial Infarction

Cardiac cell therapy is a strategy to treat patients with chronic myocardial infarction (MI). No consensus exists regarding the optimal cell type. First, a comparison between autologous bone marrow-derived mononuclear cells (BMMNC) and mesenchymal stem cells (MSC) on therapeutic efficacy after MI wa...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Cardiovasc Transl Res
Main Authors: van der Spoel, T. I. G., Gathier, W. A., Koudstaal, S., van Slochteren, F., of Lorkeers, S. Jansen, Sluijter, J. P. G., Hoefer, I. E., Steendijk, P., Cramer, M. J. M., Doevendans, P. A., van Belle, E., Chamuleau, S. A. J.
Formato: Artigo
Idioma:Inglês
Publicado em: Springer US 2015
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4623074/
https://ncbi.nlm.nih.gov/pubmed/26382088
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12265-015-9643-3
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados